Screener
Theravance Biopharma TBPH Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Theravance Biopharma’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 8:00 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-093773
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Shareholders’ Equity | ||
| Preferred shares, $0.00001 par value per share: 230 shares authorized, no shares issued or outstanding | — | — |
| Ordinary shares, $0.00001 par value per share: 200,000 shares authorized; 51,891 and 51,069 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 1 | 1 |
| Additional paid-in capital | 1,160,238 | 1,156,288 |
| Accumulated other comprehensive income (loss) | (76) | 61 |
| Accumulated deficit | (870,458) | (859,627) |
| Total shareholders’ equity | 289,705 | 296,723 |
| Total liabilities and shareholders’ equity | $469,770 | $485,570 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Theravance Biopharma's total liabilities & equity?
- Theravance Biopharma (TBPH) reported total liabilities & equity of $469.77M in Q2 2026.
- How has Theravance Biopharma's total liabilities & equity changed year-over-year?
- Theravance Biopharma's total liabilities & equity increased by 10.3% year-over-year, from $426.04M to $469.77M.
- What is the long-term trend for Theravance Biopharma's total liabilities & equity?
- Over 5 years (2020 to 2025), Theravance Biopharma's total liabilities & equity has grown at a 0.7% compound annual growth rate (CAGR), from $469.06M to $485.57M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Theravance Biopharma's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude